Richard Sullivan
#162,209
Most Influential Person Now
British oncologist
Richard Sullivan's AcademicInfluence.com Rankings
Richard Sullivanmedical Degrees
Medical
#3284
World Rank
#3747
Historical Rank
Oncology
#231
World Rank
#239
Historical Rank
Download Badge
Medical
Why Is Richard Sullivan Influential?
(Suggest an Edit or Addition)Richard Sullivan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development (2015) (1844)
- The burden of disease in older people and implications for health policy and practice (2015) (1319)
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study (2020) (968)
- Economic burden of cancer across the European Union: a population-based cost analysis. (2013) (794)
- Delivering affordable cancer care in high-income countries. (2011) (656)
- A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). (2015) (627)
- The global burden of women’s cancers: a grand challenge in global health (2017) (606)
- Mortality due to cancer treatment delay: systematic review and meta-analysis (2020) (459)
- Planning cancer control in Latin America and the Caribbean. (2013) (404)
- Challenges to effective cancer control in China, India, and Russia. (2014) (401)
- Global cancer surgery: delivering safe, affordable, and timely cancer surgery. (2015) (383)
- The growing burden of cancer in India: epidemiology and social context. (2014) (328)
- Economic Burden of Bladder Cancer Across the European Union. (2016) (209)
- Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study (2020) (191)
- The State of Lung Cancer Research: A Global Analysis (2016) (168)
- Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. (2016) (164)
- Delivery of affordable and equitable cancer care in India. (2014) (159)
- Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency (2020) (153)
- Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysis (2016) (142)
- Cancer survival in England and Wales at the end of the 20th century (2008) (130)
- Future cancer research priorities in the USA: a Lancet Oncology Commission. (2017) (125)
- Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. (2014) (124)
- ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. (2016) (122)
- Cancer Control in Bangladesh (2013) (121)
- Trends in the global funding and activity of cancer research (2008) (112)
- Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. (2015) (108)
- Sustainable care for children with cancer: a Lancet Oncology Commission. (2020) (107)
- New policies to address the global burden of childhood cancers. (2013) (105)
- Global Surgery 2030: a roadmap for high income country actors (2016) (104)
- Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs Fund (2017) (102)
- The COVID‐19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global (2020) (97)
- Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study (2021) (93)
- ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016 (2016) (86)
- Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks. (2017) (85)
- Online information needs of cancer patients and their organizations (2011) (80)
- Eradicating polio in Pakistan: an analysis of the challenges and solutions to this security and health issue (2016) (79)
- The impact of the 'Clinical Trials' directive on the cost and conduct of non-commercial cancer trials in the UK. (2007) (76)
- Delivering modern, high-quality, affordable pathology and laboratory medicine to low-income and middle-income countries: a call to action (2018) (72)
- How may clinical research improve healthcare outcomes? (2011) (71)
- Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study (2017) (70)
- Changing global policy to deliver safe, equitable, and affordable care for women’s cancers (2017) (69)
- Cancer research in India: national priorities, global results. (2014) (69)
- Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationship. (2014) (66)
- A narrative review of health research capacity strengthening in low and middle-income countries: lessons for conflict-affected areas (2019) (66)
- How do the media report cancer research? A study of the UK's BBC website (2008) (66)
- Global Surgery 2030: Evidence and solutions for achieving health, welfare, and economic development. (2015) (63)
- Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London (2020) (61)
- Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the 27 European Union member states. (2013) (60)
- A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). (2017) (57)
- The SIOPE strategic plan: a European cancer plan for children and adolescents (2015) (56)
- Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit? (2016) (56)
- An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries. (2021) (53)
- Patient Mobility for Elective Secondary Health Care Services in Response to Patient Choice Policies: A Systematic Review (2016) (50)
- The impact of cancer research: how publications influence UK cancer clinical guidelines (2008) (50)
- An assessment of the barriers to accessing the Basic Package of Health Services (BPHS) in Afghanistan: was the BPHS a success? (2016) (46)
- The European Cancer Patient’s Bill of Rights, update and implementation 2016 (2016) (44)
- ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe. (2017) (42)
- Radiation Therapy Research: A Global Analysis 2001-2015. (2018) (42)
- Delivery of Global Cancer Care: An International Study of Medical Oncology Workload (2017) (42)
- Economics of Cancer Medicines: For Whose Benefit? (2017) (42)
- A catalyst for change: the European cancer Patient's Bill of Rights. (2014) (41)
- “Nudge” in the clinical consultation – an acceptable form of medical paternalism? (2014) (41)
- Policy and priorities for national cancer control planning in low- and middle-income countries: Lessons from the Association of Southeast Asian Nations (ASEAN) Costs in Oncology prospective cohort study. (2017) (40)
- Cancer Care for Refugees and Displaced Populations: Middle East Conflicts and Global Natural Disasters. (2018) (40)
- Health technology assessment in universal health coverage (2013) (40)
- Cancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis? (2020) (40)
- Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK (2021) (39)
- [Breast cancer in the early stage]. (2012) (39)
- Affordability of cancer care in the United Kingdom - Is it time to introduce user charges? (2014) (39)
- Understanding the impact of public policy on cancer research: a bibliometric approach. (2010) (38)
- Dispelling the myths around cancer care delivery: It's not all about costs (2014) (38)
- Short-term breast cancer survival in relation to ethnicity, stage, grade and receptor status: national cohort study in England (2016) (37)
- Cancer patients need better care, not just more technology (2017) (37)
- Mapping the European cancer research landscape: An evidence base for national and Pan-European research and funding. (2018) (36)
- Children with cancer: driving the global agenda. (2013) (35)
- The State of Research and Development in Global Cancer Surgery (2012) (35)
- ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe (2017) (35)
- Documenting attacks on health workers and facilities in armed conflicts (2016) (34)
- Choosing Wisely India: ten low-value or harmful practices that should be avoided in cancer care. (2019) (34)
- Creating a low-cost virtual reality surgical simulation to increase surgical oncology capacity and capability (2019) (33)
- The Role of Funding and Policies on Innovation in Cancer Drug Development (2010) (33)
- 21 Five years of EMA-approved systemic cancer therapies for solid tumours – a comparison of two thresholds for meaningful clinical benefit (2017) (33)
- Determinants of Patient Mobility for Prostate Cancer Surgery: A Population-based Study of Choice and Competition. (2017) (33)
- Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action. (2019) (33)
- A Survey of Public Funding of Cancer Research in the European Union (2006) (32)
- Cancer care workforce in Africa: perspectives from a global survey (2019) (31)
- Cancer and mental health--a clinical and research unmet need. (2013) (31)
- A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy (2015) (30)
- Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in London (2021) (30)
- Disinformation and Epidemics: Anticipating the Next Phase of Biowarfare (2020) (30)
- Screening for Cancer: Considerations for Low- and Middle-Income Countries (2015) (29)
- Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey (2021) (29)
- Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients (2018) (28)
- The effect of explosive remnants of war on global public health: a systematic mixed-studies review using narrative synthesis. (2017) (28)
- Priorities for cancer research in low- and middle-income countries: a global perspective (2022) (27)
- Surgical Services for Cancer Care (2015) (26)
- Addressing COVID-19 in humanitarian settings: a call to action (2020) (25)
- Critical appraisal of translational research models for suitability in performance assessment of cancer centers. (2012) (25)
- The role of public health information in assistance to populations living in opposition and contested areas of Syria, 2012–2014 (2017) (25)
- The challenge of cancer in middle-income countries with an ageing population: Mexico as a case study (2015) (25)
- The state of research into children with cancer across Europe: new policies for a new decade (2011) (24)
- Online information as a decision making aid for cancer patients: recommendations from the Eurocancercoms project. (2012) (24)
- Developing institutions for cancer care in low-income and middle-income countries: from cancer units to comprehensive cancer centres. (2018) (24)
- High lung cancer surgical procedure volume is associated with shorter length of stay and lower risks of re-admission and death: National cohort analysis in England. (2016) (24)
- Lockdown is not egalitarian: the costs fall on the global poor (2020) (23)
- The impact of national non-pharmaceutical interventions (‘lockdowns’) on the presentation of cancer patients (2021) (23)
- Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning. (2018) (22)
- European Non-Communicable Respiratory Disease Research, 2002-13: Bibliometric Study of Outputs and Funding (2016) (22)
- Economic burden of malignant blood disorders across Europe: a population-based cost analysis. (2016) (21)
- The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study. (2021) (21)
- Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based Study (2017) (21)
- Intelligence and global health: assessing the role of open source and social media intelligence analysis in infectious disease outbreaks (2018) (21)
- Cancer in Africa: the way forward (2019) (21)
- "Nudge" and the epidemic of missed appointments. (2016) (20)
- Cancer in Europe: Death sentence or life sentence? (2016) (20)
- Cancer and COVID-19 vaccines: a complex global picture (2021) (20)
- Darwin, medicine and cancer (2010) (20)
- The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration (2020) (19)
- Statistical analyses in Swedish randomised trials on mammography screening and in other randomised trials on cancer screening: a systematic review (2015) (19)
- Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study. (2021) (19)
- Conflicts of interest statements on biomedical papers (2015) (19)
- Using Low-Cost Virtual Reality Simulation to Build Surgical Capacity for Cervical Cancer Treatment (2019) (19)
- The Cost Disease (2013) (18)
- The economic burden of cancer care for Syrian refugees: a population-based modelling study. (2020) (17)
- Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit? (2017) (17)
- Why do we love medicines so much? (2010) (17)
- Lessons learned from the casualties of war: battlefield medicine and its implication for global trauma care (2015) (17)
- Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems. (2021) (17)
- COVID-19, palliative care and public health (2020) (16)
- Affordable cancer care: pipedream or achievable reality? (2014) (16)
- The impact of armed conflict on cancer among civilian populations in low- and middle-income countries: a systematic review (2020) (16)
- Health system strengthening: Integration of breast cancer care for improved outcomes (2020) (16)
- The European Code of Cancer Practice. (2021) (15)
- Financial Impact of Complex Cancer Surgery in India: A Study of Pancreatic Cancer (2018) (15)
- Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box? (2015) (15)
- A roadmap for restoring trust in Big Data. (2018) (15)
- COVID-19—Impact on DNR Orders in the Largest Cancer Center in Jordan (2020) (15)
- Colorectal cancer in Europe and Australia: challenges and opportunities for the future (2008) (15)
- North–South inequities in research collaboration in humanitarian and conflict contexts (2019) (15)
- Cancer control in small island nations: from local challenges to global action. (2019) (14)
- The Centre for Defence Healthcare Engagement: a focus for Defence Engagement by the Defence Medical Services (2017) (14)
- Avoiding the zero sum game in global cancer policy: beyond 2011 UN high level summit. (2011) (14)
- Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study (2021) (14)
- The global burden of women ’ s cancers : an unmet grand challenge in global health (2016) (14)
- Health policy: Putting a price on cancer (2016) (14)
- Cancer groundshot: going global before going to the moon. (2018) (14)
- Cancer and COVID-19: economic impact on households in Southeast Asia (2020) (13)
- Perioperative therapies - Enhancing the impact of cancer surgery with repurposed drugs. (2017) (13)
- Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening (2016) (13)
- Additional challenges faced by cancer patients in Gaza due to COVID-19 (2020) (13)
- The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research. (2021) (13)
- Medical oncology in India: Workload, infrastructure, and delivery of care (2019) (13)
- An analysis of research activity in major UK cancer centres. (2011) (13)
- Medical oncology job satisfaction: Results of a global survey. (2019) (13)
- European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287 (2003) (13)
- Tobacco in post-conflict settings: the case of Iraq (2017) (13)
- The good, the bad, and the ugly: effect of regulations on cancer research. (2008) (13)
- The media and cancer: education or entertainment? An ethnographic study of European cancer journalists (2014) (13)
- Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals (2018) (12)
- Balancing Equity and Advancement: The Role of Health Technology Assessment in Radiotherapy Resource Allocation. (2017) (12)
- Has the US Cancer Centre model been ‘successful’? Lessons for the European cancer community (2009) (12)
- Cancer Registration in the Middle East, North Africa, and Turkey: Scope and Challenges (2021) (12)
- Medical intelligence, security and global health: the foundations of a new health agenda (2016) (12)
- How are we going to rebuild public health in Libya? (2011) (12)
- Making Outcome-Based Payment a Reality in the NHS (2019) (12)
- Global public and philanthropic investment in childhood cancer research: systematic analysis of research funding, 2008-16. (2019) (12)
- Cancer care in times of conflict: cross border care in Pakistan of patients from Afghanistan (2020) (12)
- ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers (2016) (12)
- The state of academic cancer surgery in the UK (2008) (12)
- Palliative Care Program Development in a Low- to Middle-Income Country: Delivery of Care by a Nongovernmental Organization in India (2018) (11)
- Medical oncology workload in Canada: infrastructure, supports, and delivery of clinical care. (2018) (11)
- Global cancer research in the era of COVID-19: a bibliometric analysis (2021) (11)
- Economic Burden of Malignant Neoplasms in the European Union (2012) (11)
- COVID-19 and the Rise of Participatory SIGINT: An Examination of the Rise in Government Surveillance Through Mobile Applications. (2020) (11)
- The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial (2020) (11)
- European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission. (2022) (10)
- How is chronic non‐communicable respiratory conditions research reported in European newspapers? An impact assessment for policy (2017) (10)
- Cancer risk and prevention in a globalised world: solving the public policy mismatch. (2012) (10)
- “Having more women humanitarian leaders will help transform the humanitarian system”: challenges and opportunities for women leaders in conflict and humanitarian health (2020) (10)
- The impacts of diabetes research from 31 European Countries in 2002 to 2013 (2018) (10)
- COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients (2021) (10)
- Participation of Lower and Upper Middle–Income Countries in Clinical Trials Led by High-Income Countries (2022) (10)
- Late translational research: putting forward a new model for developing new anti‐cancer treatments that addresses the needs of patients and society (2019) (10)
- Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians (2021) (10)
- Medical Oncology Workload in Europe: One Continent, Several Worlds. (2019) (10)
- Impact of patient choice and hospital competition on patient outcomes after prostate cancer surgery: A national population‐based study (2019) (10)
- India's new health scheme: what does it mean for cancer care? (2019) (10)
- Analysis of Global Pediatric Cancer Research and Publications (2020) (10)
- Molecular biomarkers and precision medicine in colorectal cancer: a systematic review of health economic analyses (2017) (9)
- Compounded trauma: A qualitative study of the challenges for refugees living with advanced cancer (2021) (9)
- A workforce survey of New Zealand medical oncologists. (2013) (9)
- Correcetions to "A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)". (2017) (9)
- Primary care and cancer: an analysis of the impact and inequalities of the COVID-19 pandemic on patient pathways (2022) (8)
- America's cancer care crisis—is Europe any better? (2013) (8)
- Shooting for the Moon or Flying Too Near the Sun? Crossing the Value Rubicon in Precision Cancer Care (2016) (8)
- Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic (2021) (8)
- One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer (2020) (8)
- Weaponizing water as an instrument of war in Syria: Impact on diarrhoeal disease in Idlib and Aleppo governorates, 2011–2019 (2021) (8)
- The contribution of Cyprus to non-communicable diseases and biomedical research from 2002 to 2013: implications for evidence-based health policy (2018) (8)
- Global cancer research in the post-pandemic world (2021) (7)
- The “Molecularly Unstratified” Patient: A Focus for Moral, Psycho-Social and Societal Research (2017) (7)
- Research on lung cancer and its funding, 2004–2018 (2020) (7)
- Mission‐oriented translational cancer research – health economics (2019) (7)
- Lung cancer research and its citation on clinical practice guidelines. (2021) (7)
- UK newspaper reporting of the NHS cancer drugs fund, 2010 to 2015: a retrospective media analysis (2018) (7)
- Re-aligning the ASCO and ESMO clinical benefit frameworks for modern cancer therapies. (2017) (7)
- Strategies for cancer prevention in India—Catching the ‘low hanging fruits’ (2014) (7)
- Alignment with Indices of A Care Pathway Is Associated with Improved Survival (2019) (7)
- The value of European immigration for high-level UK research and clinical care: cross-sectional study (2018) (7)
- Cancer burden and health systems in India 3 Delivery of aff ordable and equitable cancer care in India (2014) (7)
- A Health Intelligence Framework for Pandemic Response: Lessons from the UK Experience of COVID-19. (2020) (7)
- Health service planning to assess the expected impact of centralising specialist cancer services on travel times, equity, and outcomes: a national population-based modelling study. (2022) (6)
- What really matters in cancer?: Putting people back into the heart of cancer policy. (2013) (6)
- Understanding the structure of a country’s health service providers for defence health engagement (2020) (6)
- Solving the jigsaw of conflict-related environmental damage: Utilizing open-source analysis to improve research into environmental health risks. (2019) (6)
- Cancer burden and health systems in India 1 The growing burden of cancer in India: epidemiology and social context (2014) (6)
- Policy challenges for cancer research: a call to arms (2007) (6)
- Analysis of media reporting of The Lancet Oncology Commission. (2012) (6)
- Economics of Pediatric Cancer in Four Eastern Mediterranean Countries: A Comparative Assessment (2020) (6)
- Gender Differences in Concerns About Participating in Cancer Research During the COVID-19 Pandemic (2021) (6)
- Prioritising locations for radiotherapy equipment in Brazil: a cross-sectional, population-based study and development of a LINAC shortage index. (2022) (6)
- Trends in drug revenue among major pharmaceutical companies: A 2010‐2019 cohort study (2021) (6)
- User Experience With Low-Cost Virtual Reality Cancer Surgery Simulation in an African Setting (2021) (6)
- Ecology of War, Health Research and Knowledge Subjugation: Insights from the Middle East and North Africa Region (2020) (5)
- Aff ordable cancer care 2 Evidence-informed frameworks for cost-eff ective cancer care and prevention in low , middle, and high-income countries (2014) (5)
- Cost‐effectiveness of precision diagnostic testing for precision medicine approaches against non‐small‐cell lung cancer: A systematic review (2021) (5)
- Small and light arms violence reduction as a public health measure: the case of Libya (2018) (5)
- International Cancer Control Partnership (2014) (5)
- Evidence-based benchmarks for use of cancer surgery in high-income countries: a population-based analysis. (2021) (5)
- The use of HUMINT in epidemics: a practical assessment (2020) (5)
- Population Screening for Cancer in High-Income Settings: Lessons for Low- and Middle-Income Economies (2019) (5)
- Mental health disorders research in Europe, 2001–2018 (2020) (5)
- Impact of the COVID-19 Pandemic on Cancer Researchers in 2020: A Qualitative Study of Events to Inform Mitigation Strategies (2021) (4)
- Achieving Value in Cancer Care-the Case of Low- and Middle-Income Countries (2014) (4)
- Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation. (2021) (4)
- Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al. (2016) (4)
- ‘Tackling cancer in the EU: The role of innovation’ (2009) (4)
- New journal authorship criteria: how ecancermedicalscience is supporting authors and readers from underserved settings (2020) (4)
- Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England (2021) (4)
- Putting public health back into the global cancer agenda. (2012) (4)
- Do contemporary randomized controlled trials meet ESMO thresholds for clinically meaningful benefit (2016) (4)
- Moonshot or groundshot: addressing Europe's cancer challenge through a patient-focused, data-enabled lens. (2019) (4)
- The UK's contribution to cancer control in low-income and middle-income countries. (2021) (4)
- Mapping the cancer patient information landscape: A comparative analysis of patient groups across Europe and North America. (2018) (4)
- Mammographic Screening in the Occupied Palestinian Territory: A Critical Analysis of Its Promotion, Claimed Benefits, and Safety in Palestinian Health Research (2020) (4)
- Clinical trial design in oncology (2004) (4)
- Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey (2022) (3)
- Association of Quality and Technology With Patient Mobility for Colorectal Cancer Surgery (2022) (3)
- Cancer control in low- and middle-income countries: time for action (2019) (3)
- Patient mobility for radical prostatectomy in the English NHS: its impact on service configuration and technology integration (2017) (3)
- Cancer research across Africa: a comparative bibliometric analysis (2022) (3)
- Changing Mortality and Place of Death in Response to Refugee Influx: A Population-Based Cross-Sectional Study in Jordan, 2005-2016. (2021) (3)
- Temporal trends in oncology drug revenue among the world’s major pharmaceutical companies: A 2010-2019 cohort study. (2021) (3)
- Why we need an intelligence-led approach to pandemics: supporting science and public health during COVID-19 and beyond (2020) (3)
- The 'Good Friday Agreement' and cancer research on the island of Ireland: Evidence for the impact of a tripartite cancer research partnership. (2020) (3)
- The Goldilocks' problem of cancer medicines. (2010) (3)
- Modelling palliative and end-of-life resource requirements during COVID-19: implications for quality care (2020) (3)
- To know or not to know? Not the only question in familial breast cancer risk communication (2011) (3)
- The Lancet Oncology Commission Global cancer surgery: delivering safe, aff ordable, and timely cancer surgery (2015) (3)
- Building affordable cancer care in low- and middle-income countries (2013) (3)
- Cancer research in the 57 Organisation of Islamic Cooperation (OIC) countries, 2008–17 (2020) (3)
- Delivering Affordable Cancer Care in High-income Countries: a Lancet Oncology Commission (2011) (3)
- 114INESMO EUROPEAN CONSORTIUM STUDY ON THE AVAILABILITY OF ANTI-NEOPLASTIC MEDICINES ACROSS EUROPE. (2014) (3)
- Cancer research in the UK: A policy review of the junior academic clinical faculty (2008) (3)
- Cyber security and the unexplored threat to global health: a call for global norms (2020) (2)
- Developing cancer care institutions for the developing world – Investigator's response (2018) (2)
- “Choosing Wisely” for Cancer Care in India (2020) (2)
- Adjuvant chemotherapy for non-small cell lung cancer: a New Zealand perspective. (2006) (2)
- Cancer Trends in Asia Cancer Control in Bangladesh (2013) (2)
- Mapping breast cancer journal publications in conflict settings in the MENA region: a scoping review (2020) (2)
- Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward. (2022) (2)
- Sanctions on Syria (2020) (2)
- The impact of Brexit on UK cancer research. (2018) (2)
- Abstract P45: A global snapshot of the impact of the COVID-19 pandemic on cancer research: Report from a Global Cancer and COVID-19 Task Force (2021) (2)
- Conference Report: Global Health Security Alliance (GLoHSA), a Product of the World Health Summit (2019) (2)
- Achieving better cancer intelligence for global cancer control (2018) (2)
- Clinical trial design in oncology: protocol design. (2004) (2)
- USA stockpiling of remdesivir: How should the world respond? (2020) (2)
- Media Reporting of Affordable Cancer Care in High Income Countries: a Lancet Oncology Commission (2011) (1)
- Choosing Wisely for Cancer Care in India (2020) (1)
- Developing geriatric oncology in low and middle income countries: What should we do first? (2012) (1)
- Determinants of Patient Mobility for Radical Prostate Cancer Radiation Therapy in the Precision Medicine Era: A Population-Based Study of Choice and Competition in England (2017) (1)
- Abstract PO-028: One piece of the jigsaw for the cancer recovery strategy: Prevalence of COVID-19 in patients with cancer (2020) (1)
- Cancer Research UK says (2003) (1)
- COVID-19 and cancer in the UK: which will prove to be the lesser of two evils? (2023) (1)
- Medical Civil–Military Relationships: A Feasibility Study of a United Kingdom Deployment in South Sudan (2019) (1)
- A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy (2015) (1)
- Cancer control in member countries of Organization of Islamic Cooperation (OIC)—A status report & İstanbul declaration by the first ladies of OIC (2018) (1)
- Delivering global cancer care: An international study of medical oncology workload. (2017) (1)
- Targeting the value of targeted therapy (2017) (1)
- Inequality and cancer: the conflict ecosystem and refugees (2019) (1)
- “Nudge” in the clinical consultation – an acceptable form of medical paternalism? (2014) (1)
- Revitalising cancer trials post-pandemic: time for reform (2023) (1)
- Weighing false hope in population anticancer drug decision making. (2019) (1)
- Mind the Graph: Foregone Health Gains in Lung Cancer. (2017) (1)
- Cancer in the older Indian population: Understanding the current context in an emerging economy. (2021) (1)
- C-CRES: COVID-19 and cancer research engagement study. (2020) (1)
- Abstract S09-03: Factors affecting COVID-19 outcomes in cancer patients: A first report from Guy’s Cancer Centre in London (2020) (1)
- Settlements and separation in the West Bank: future implications for health (2014) (1)
- Screening mammography: Authors’ response to Nyström and Tabar and colleagues (2015) (1)
- Methodology, results, and publication of oncology clinical trials: Insights from all the world’s randomized controlled trials (RCTs) 2014-2017. (2020) (1)
- Global perspectives on clinical cancer research: A comparison of randomized controlled trial (RCT) design and outcomes across high income and low-middle income countries. (2020) (1)
- The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence (2022) (1)
- 9LBA Delivering safe and affordable cancer surgery to all - a Lancet Oncology Commission (2015) (1)
- Author and Subject Index (2002) (0)
- Molecular biomarkers and precision medicine in colorectal cancer: Value for Money? (2018) (0)
- Mental health disorders research in the countries of the Organisation of Islamic Cooperation (OIC), 2008–17, and the disease burden: Bibliometric study (2021) (0)
- Economic downturns , universal healthcare coverage , and cancer mortality in high-and middle-income countries , 1990 – 2010 : a longitudinal analysis (2016) (0)
- IN33 THE COST OF BREAST CANCER: A GLOBAL PERSPECTIVE (2015) (0)
- Defence healthcare engagement is about more than simply the humanitarian response (2020) (0)
- on the aforementioned areas would provide a far better contribution to patient outcome and wellbeing. (2010) (0)
- 4107 ORAL The State of Research Into Children With Cancer Across Europe: Results of Key Opinion Leaders Survey and Innovative Policy Strategies for the Next Decade (2011) (0)
- Do not use robotic surgery in oncology patients when conventional surgical approaches are equally effective - Authors' reply. (2019) (0)
- Toward affordable cancer drugs: Do we need firmer price negotiation, me-too drugs, or a biosimilar silver bullet? (2020) (0)
- ESO Society Symposium: Celebrating 30 years of ESO and 50 issues of Cancer World. Cancer 2020: The road to personalized cancer care (2012) (0)
- Socioeconomic Factors, Urological Epidemiology and Practice Patterns Re: Delivering Affordable Cancer Care in High-Income Countries (2011) (0)
- Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et al. (2016) (0)
- 1407 The European Strategic Plan for children and adolescents with cancer (2015) (0)
- Personalised Cancer Care Affordable (2012) (0)
- Disparities in COVID-19 severity and risk of death in cancer patients: Experiences from a U.K. cancer center. (2020) (0)
- Anonymised data would disable cancer registries (2001) (0)
- Abstract S12-03: Clinical and demographic characteristics associated with shorter time to COVID-19 death (2021) (0)
- The spin-off to civilian medical practice in the UK and USA from medical research developed during conflict (2020) (0)
- PV-0252 From theory to practice: assessing the use of radiotherapy in population based cancer registries (2019) (0)
- The Right Diagnosis: The Role of Pathology in Health System Strengthening (2017) (0)
- Medicinal mushrooms and breast cancer (2011) (0)
- Abstract P28: COVID-19 infection and mortality in patients with skin malignancies receiving systemic anti-cancer therapy (SACT): The Guy’s Cancer Centre experience (2021) (0)
- PCN490 MAKING OUTCOME-BASED PAYMENT A REALITY IN THE NATIONAL HEALTH SERVICE FOR ENGLAND (2019) (0)
- A CONCEPTUAL FRAMEWORK FOR THE STRUCTURE OF A COUNTRY’S HEALTH SERVICE PROVIDERS: A CONCEPTUAL FRAMEWORK FOR THE STRUCTURE OF A COUNTRY’S HEALTH SERVICE PROVIDERS (2019) (0)
- Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al. (2016) (0)
- Corrigendum to "ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe": Ann Oncol 2016; 27 (8): 1423-1443. (2020) (0)
- Global surveillance of cancer survival: the impact of real-world data on cancer control.: Ecancer News (2019) (0)
- Clinically meaningful benefit: Half of the value equation. (2017) (0)
- 81INEVOLUTION OF THE PRICING AND REIMBURSEMENT STRUCTURE OF CANCER THERAPIES IN EUROPE. (2014) (0)
- Mapping the research on warfare and health, 1946-2017 (2019) (0)
- Corrigendum to “Has the US Cancer Centre model been ‘successful’? Lessons for the European cancer community” [Mol. Oncol. 3 (2009) 192–203] (2009) (0)
- Mental health research in the countries of the Organisation of Islamic Cooperation (OIC), 2008-17 (2019) (0)
- Platinum Priority – Bladder Cancer (2016) (0)
- 42: CARO Fellowship Staying on Target: Optimizing Utilization of Precision Radiotherapy (2016) (0)
- 565O_PR Predictors of financial catastrophe following cancer in a high-middle-income Asian country (2016) (0)
- G538 Global public and philanthropic investment in childhood cancer research: systematic analysis of research funding over nine years, 2008 – 2016 (2019) (0)
- The rise of immuno-oncology in China: a challenge to western dominance? (2023) (0)
- Putting public health back into the global cancer agenda. (2012) (0)
- THE EUROPEAN ROADMAP TO HORIZON 2020 FOR CHILDREN AND ADOLESCENTS WITH CANCER - A LONG TERM SUSTAINABLE STRATEGY (2015) (0)
- Syddansk Universitet Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients (2018) (0)
- Cancer control in Chile - Authors' reply. (2013) (0)
- Abstract P44: Factors affecting COVID-19 outcomes in cancer patients from Guy’s Cancer Center and King's College Hospital (2021) (0)
- PCN60 COST-EFFECTIVENESS OF PRECISION DIAGNOSTIC TESTING AND PRECISION MEDICINE FOR NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW (2020) (0)
- Genes, genes, genes. (2013) (0)
- Adoption of robotic surgery: driven by market competition or a desire to improve patient care? - Authors' reply. (2018) (0)
- 1 BACKGROUND AND IMPLEMENTATION PLAN FOR THE EUROPEAN CANCER PATIENT’S BILL OF RIGHTS, 2016 (ARCHIVE) ECC Members (2017) (0)
- LUNG CANCER RESEARCH OUTPUT IN AUSTRALIA IS POORER THAN THE GENERALLY POOR INTERNATIONAL LEVEL (2016) (0)
- Climate emergencies and health system resilience collaborative research action (CHESS): challenges and best practice from the UK and Australia (2022) (0)
- SP-0297: Method of development of ESMO Magnitude of Clinical Benefit applicable for radiotherapy? (2017) (0)
- Informal Providers—Ground Realities in South Asian Association for Regional Cooperation Nations: Toward Better Cancer Primary Care: A Narrative Review (2022) (0)
- Molecular epidemiology of carbapenemase-producing Acinetobacter spp. from Israel, 2001-2006: earliest report of blaNDM predating the oldest known blaNDM-positive strains (2022) (0)
- What is the Optimum Utilization of Cancer Surgery in High Income Settings? A National Population Based Analysis (2020) (0)
- 131. Carbapenemase-producing Acinetobacter spp. from Israel, 2001-2006: earliest report of blaNDM predating the oldest known blaNDM-positive strains (2022) (0)
- Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery (2023) (0)
- Conflicts of interest statements on biomedical papers (2014) (0)
- Abstract LB076: Association between regional COVID-19 hospitalizations and treatment delays amongst confirmed cancer patients in England, UK (2021) (0)
- Technology and cancer systems : creating better policy to enhance equality (2019) (0)
- Delivery of meaningful cancer care: Evaluating benefit and cost of cancer therapies using ASCO and ESMO frameworks. (2017) (0)
- Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity (2022) (0)
- Cancer registration in the Middle East, North Africa, and Turkey (MENAT) region: A tale of conflict, challenges, and opportunities (2022) (0)
- Global colorectal cancer research, 2007‐2021: Outputs and funding (2022) (0)
- Report on the 1st Indian Cancer Congress 2013 (2013) (0)
- Impact of patient choice and hospital competition on patient outcomes after rectal cancer surgery: A national population‐based study (2022) (0)
- Access to basic surgical oncologic services in 54 countries: Where to go from here? (2015) (0)
- The Influence of Social Determinants of Health on Primary and Secondary Cancer Prevention Health Seeking Behaviors Among Refugees in Middle East and North Africa Host Countries (2018) (0)
- Cancer Medicines: What Is Essential and Affordable in India? (2022) (0)
- Media Coverage of Cancer Therapeutics: A review of literature. (2023) (0)
- Abstract A059: The influence of social determinants of health on primary and secondary cancer prevention health-seeking behaviors among refugees in Middle East and North Africa host countries (2020) (0)
- Editorial: The effects of COVID-19 on cancer research methods & strategies (2022) (0)
- Policy Recommendations to Address Financial Toxicity Following Cancer in Low- and Middle-Income Countries: One Size Does Not Fit All (2018) (0)
- Integrated Cancer Centre, King's Health Partners, Chairman of European Cancer Research Managers Forum, Guy's Hospital, London, UK (2011) (0)
- Abstract 92: Clinical Care and Short-Term Survival Outcomes for Women with Breast Cancer in Gaza, Occupied Palestinian Territory (2021) (0)
- Can we cure the price problem for new cancer technologies (2017) (0)
- Cancer care workforce in Africa: perspectives from a global survey (2019) (0)
- Virtual reality and surgical oncology (2023) (0)
- The spin-off to civilian medical practice in the UK and USA from medical research developed during conflict (2020) (0)
- TheCOVID-19PANDEMIC:ARapidGlobalresponsefor ChildrenwithCancerfrom SIOP,COG,SIOP-E,SIOP-PODC,IPSO,PROS, CCIandStJudeGlobal (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Richard Sullivan?
Richard Sullivan is affiliated with the following schools:
